Delivery Order SPE2DB24D2109-SPE2DB25FHXYR
Award Date 9/25/25
Potential Completion Date 9/26/25
Potential Value $55K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $24,855.50 to AmerisourceBergen Drug Corp for Mounjaro 15 mg/0.5 mL pen injections on September 10, 2025, with completion scheduled for September 11, 2025. This firm fixed-price, non-set-aside delivery order represents a routine pharmaceutical procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro (tirzepatide) 7.5 mg/0.5 mL pen injections, with a contract ceiling value of $6,235.50. This competitively awarded, firm fixed-price delivery order was issued on August 4, 2025, with an ultimate completion date of August 5, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Mounjaro 2.5 mg/0.5 mL pens on April 25, 2025, with a ceiling value of $1,632.54 and an ultimate completion date of April 28, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor's Corporate Office division. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania. Mounjaro (tirzepatide) is a...
- The Defense Logistics Agency awarded a delivery order valued at $2,176.72 to AmerisourceBergen Drug Corp for Mounjaro 15 mg/0.5 ml pen injection units, with performance in Conshohocken, Pennsylvania and completion by August 4, 2025. This competitively awarded, firm fixed-price contract represents a continuation of pharmaceutical supply under AmerisourceBergen's broader relationship with DLA, utilizing no set-aside designation. The product supplied—Mounjaro (tirzepatide)—is a diabetes...
- The Defense Logistics Agency awarded a $48,976.20 delivery order to AmerisourceBergen Drug Corp for Mounjaro (tirzepatide) 10 mg/0.5 mL pen injections on September 12, 2025, with completion targeted for September 15, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. Mounjaro is a GLP-1 receptor agonist medication used for diabetes management,...
- The Defense Logistics Agency (DLA) awarded a $9,588.60 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Mounjaro 10 mg/0.5 ml pen injectors (0.5ml). This firm fixed-price delivery order, with an ultimate completion date of September 19, 2025, represents a competitive award with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication (tirzepatide) used for glycemic control in...
- The Defense Logistics Agency awarded a delivery order valued at $1,904.63 to AmerisourceBergen Drug Corp for Mounjaro (tirzepatide) 15 mg/0.5 ml pens on July 22, 2025, with completion scheduled for July 23, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Mounjaro is a GLP-1 receptor agonist used for diabetes management, representing part of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro (tirzepatide) 7.5 mg/0.5 mL pen injections with a ceiling value of $1,088.36. This contract, issued on May 23, 2025, represents a firm fixed price delivery order with an ultimate completion date of May 27, 2025 and carries no set-aside designation. The award was made through competitive procurement processes and serves as a child contract under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,162.70 for Mounjaro 5 mg/0.5 mL pen injectors on August 20, 2025, with completion expected by August 21, 2025. This firm fixed-price delivery order was competitively awarded without set-aside provisions and will be performed at the vendor's corporate headquarters in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication used for glycemic control in patients with type 2 diabetes. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,491.10 to AmerisourceBergen Drug Corp on April 24, 2025, for Mounjaro 10 mg/0.5 mL pen injectors. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The product will be delivered to AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of April 25, 2025. Mounjaro is a diabetes medication used for managing...